Mycenax Biotech Company Description

Mycenax Biotech Inc., a contract development and manufacturing organization company, provides biopharmaceutical services and solutions for drug development and production in Taiwan, Japan, Korea, Singapore, rest of the Asia-Pacific regions, Europe, and the United States.

The company’s services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production.

It offers plasmid DNA, antibody-drug conjugates, cell and gene therapy, and exosomes products and services.

The company was founded in 2001 and is headquartered in Zhubei, Taiwan.

Mycenax Biotech Inc.

Country	Taiwan
Founded	2001
Industry	Biotechnology
Sector	Healthcare
Employees	387
CEO	Pei-Jiun Chen

Contact Details

Address: No. 66, Shengyi 2nd Rd. Zhubei, 302041 Taiwan
Phone	886 3 667 0880
Website	mycenax.com

Stock Details

Ticker Symbol	4726
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0004726005
SIC Code	2836

Key Executives

Name	Position
Pei-Jiun Chen	President Chief Executive Officer and Chairman
Chin-Hao Liang	Associate Vice President of Administration and Management Division
Wei-I Chou	Associate Vice President of Pharmaceutical Development Division